LB Pharmaceuticals Inc (LBRX) Cash Flow Statement
LB Pharmaceuticals Inc (LBRX) generated -$82.4M of operating cash flow over the twelve months to 2026-06-30, spent $435000 on capital expenditure and had free cash flow of -$82.8M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LBRXLB Pharmaceuticals IncFollow LBRX — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Operating cash flow | -53.1 | -35.2 | -82.4 | |
| Capital expenditure | 0.8 | 0.1 | -0.4 | |
| Free cash flow | -53.8 | -35.3 | -82.8 | |
| Stock-based compensation | 3.1 | 4.2 | — |
USD millions · SEC XBRL
LB Pharmaceuticals Inc — questions
- What is LB Pharmaceuticals Inc's operating cash flow?
- -$82.4M over the twelve months to 2026-06-30.
- How much does LB Pharmaceuticals Inc spend on capital expenditure?
- $435000 over the twelve months to 2026-06-30.
- What is LB Pharmaceuticals Inc's free cash flow?
- -$82.8M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from LB Pharmaceuticals Inc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.